SCHEMBL15740201

SCHEMBL15740201

CC1(C)O[C@@H]2[C@@H](CO[Si](C)(C)C(C)(C)C)NC(/C(C#N)=C/O)[C@@H]2O1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17178460 1.00 — —
SCHEMBL15740210 0.79 — —
SCHEMBL19372789 0.77 — —
SCHEMBL15718077 0.77 — —
SCHEMBL7099671 0.75 MAPT (0.31) —
SCHEMBL15740154 0.73 — —
SCHEMBL15740204 0.71 — —
SCHEMBL15719022 0.71 MAPT (0.32) —
SCHEMBL15740105 0.70 — —
SCHEMBL19664244 0.69 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3251674-A2 ANTIVIRAL AZASUGAR-CONTAINING NUCLEOSIDES BioCryst Pharmaceuticals, Inc. (US) 2017-12-06 — — EP disclosed
WO-2014078778-A2 ANTIVIRAL AZASUGAR-CONTAINING NUCLEOSIDES BIOCRYST PHARMACEUTICALS, INC. (US) 2014-05-22 — — WO disclosed
Send feedback